Kai Huang, MD

Rally for Kids: A successful pickleball tournament fundraiser for St. Vincent Children’s Hospital! My partner and I were proud to take 2nd place. Hoping to see even more physicians join in next time

Dr. Manny Gabriel is running for Chair of the American College of Surgeons Young Fellows Association! Check your email TOMORROW for voting info—let’s show our support and vote ✅ #HealthcareLeadership #MedicalExcellence #AmericanCollegeofSurgeons

@IowaMed Congratulations @drvikasdudeja

Vikas Dudeja, MBBS, FACS, has been appointed chair and department executive officer of the Department of Surgery. He will begin in his new role on June 30. spr.ly/6019LIIUV

@SteveCaiMD @LIRR @Mets @SNY_Mets Mets are doing really well this year. I bet they are going to win the championship.

Love my commute into #NYC on the @LIRR. On approach, train conductor announced “Next stop, the GREAT @Mets -Willets Point” I’ll be stopping by here until the end of October! #LFGM #LGM #OMG @SNY_Mets

@ASBrS What a great meeting and reunion with @UIowa_Surgery mentors, colleagues and friends ! Continue to learn new techniques , keep up with the updates from the experts and provide breast cancer patients in the community with the best care.

Early-stage TNBC who did not undergo adjuvant or neoadjuvant chemotherapy, breast cancer tissue with a higher abundance of tumor infiltrating lymphocyte (TIL) levels was associated with significantly better survival.5-yr OS 95% vs 82%. DOI: 10.1001/jama.2024.3056. ->guide chemo

@MDingIt2023 @clemensmd @KellyKhunt Agree. Many medical oncologists still don’t know why we need 2mm margin for DCIS but no margin on ink for invasive tumor

@clemensmd @KellyKhunt Why isn't this included in NCCN v1.2024?

<2mm margins sufficient in DCIS!@MDAndersonNews Drs. @KellyKhunt and Kuerer #breastreconstruction #plasticsurgery #endcancer twitter.com/bsauser/status…

Another 5K with Eric PI day Leonardo Da Vinci school fund raise for Greater Green Bay Habitat for Humanity.

Women with atypia detected more recently have lower rates of subsequent cancers detected, which might be associated with changes to mammography and biopsy techniques identifying forms of atypia that are more likely to represent overdiagnosis. BMJ DOI: 10.1136/bmj-2023-077039

Thank you Dr.Chatterjee, Dr. Czerniecki putting together this amazing oncoplastic course, Dr.Homsy and all the faculties for the wonderful presentations. As a breast surgeon always enthusiastic at oncoplastic techniques , I feel very comfortable to incorporate them to my practice

The combination of screening, stage I- III treatment, and metastatic treatment -> a 58% reduction in breast CA mortality in 2019; treatment of metastatic breast CA, treatment of stage I - III breast CA, and mammography screening ->29%, 47,% and 25% of the reduction respectively.

#AudioVisualAbstract : Overall Survival Following #NeoadjuvantChemotherapy Versus #AdjuvantChemotherapy in Clinically Node Negative T1 Triple Negative #BreastCancer @KaiHuangMD1 @UIowa_Surgery rdcu.be/dvfqo

Great oncoplastic course coming up!

@SocSurgOnc Contralateral mastectomy without reconstruction to achieve asymmetry - with the popularity of aesthetic flat closure, either simultaneously or elective , I think it’s a option that we can provide for our patients. I am wondering how the society think about this concept .

This #FeaturedArticle from Annals of Surgical Oncology demonstrates patients are satisfied with their decision to undergo contralateral mastectomy, supporting surgeons to offer women this option. 📃surgonc.org/annals/feature…

Excise is more important than you think- high levels of leisure-time physical activity were associated with a 10% reduction in breast cancer risk in premenopausal women after adjustment of BMI. DOI: 10.1200/JCO.23.01101

@MarkMishraMD Wondering is there a subgroup analysis of axillary recurrence for T3 patients Vs.T1-2, and patients with SLNs versus ALND

NSABP-B51 study findings: In patients initially node-positive but achieved pCR in nodes after neoajduvant chemotherapy, randomization to either no RNI or RNI (with variations based on surgery type) showed no significant difference in recurrence-free or overall survival. #radonc

RT to regional nodes in early BC significantly reduced BC mortality and all-cause mortality in trials done after the 1980s, but not in older trials(EBCTCG). 15 yr BC mortality reduce for LN -, 1.6%; 1-3 LN +2.7%; ≥4 LN+ 4.5% . Lancet 2023. DOI: 10.1016/S0140-6736(23)01082-6

Sound Trial(omitting SLNB in early BC): SLNB vs No biopsy. Medium follow up 5.7 yrs. 5-yr DFS：97.7% vs 98.0%（p=0.67，HR，0.84，90% CI：0.45～1.54，non inferiority P=0.02） 5-yr LR ：1.7% vs 1.6% 5-yr distant metastasis ：1.8% vs. 2.0% 5-yr all cause mortality：3.0% vs. 2.6%

Time to start omitting regional nodal irradiation in favorable-risk 1-3 N+/Oncotype <25 breast cancer patients? In scndry analysis of (~4000! women in) SWOG S1007 out in @JAMAOnc 5y LRR after BCS + RNI: 0.85%(!) 5y LRR after BCS and *NO* RNI: 0.55%(!!) jamanetwork.com/journals/jamao…